Evidence map›Paper›PMID 28445750›Full record

ArticleBiophysical journal2017

Effect of Phosphorylation on a Human-like Osteopontin Peptide.

Samuel Lenton, Marco Grimaldo, Felix Roosen-Runge, Frank Schreiber, Tommy Nylander, Roger Clegg, Carl Holt, Michael Härtlein, Victoria García Sakai, Tilo Seydel and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Dissecting physical structure of calreticulin, an intrinsically disordered CaJournal of biomolecular structure & dynamics · 2018
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 5 countries.

Samuel LentonEnvironment, Physical Sciences and Applied Mathematics (EPSAM), Keele University, Staffordshire, United Kingdom; Institut Laue-Langevin, Grenoble, France; Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom.
Marco GrimaldoInstitut Laue-Langevin, Grenoble, France; Institut für Angewandte Physik, University of Tübingen, Tübingen, Germany.
Felix Roosen-RungeInstitut Laue-Langevin, Grenoble, France; Department of Chemistry, Division of Physical Chemistry, Lund University, Lund, Sweden.
Frank SchreiberInstitut für Angewandte Physik, University of Tübingen, Tübingen, Germany.
Tommy NylanderDepartment of Chemistry, Division of Physical Chemistry, Lund University, Lund, Sweden.
Roger CleggHannah Research Institute, Ayr, Scotland, United Kingdom.
Carl HoltInstitute of Molecular, Cell and Systems Biology, University of Glasgow, Glasgow, United Kingdom.
Michael HärtleinInstitut Laue-Langevin, Grenoble, France.
Victoria García SakaiISIS Facility, Rutherford Appleton Laboratory, Chilton, Didcot, United Kingdom.
Tilo SeydelInstitut Laue-Langevin, Grenoble, France.
Susana C Marujo TeixeiraDepartment of Chemical and Biomolecular Engineering, University of Delaware, Newark, Delaware; The NIST Centre for Neutron Research, National Institute of Standards and Technology, Gaithersburg, Maryland. Electronic address: scm5@nist.gov.
Institut Laue-Langevin · FRUniversity of Tübingen · DEHannah Research Foundation · GBLund University · SERutherford Appleton Laboratory · GBUniversity of Delaware · USUniversity of Glasgow · GBUniversity of Leeds · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The last decade established that the dynamic properties of the phosphoproteome are central to function and its modulation. The temporal dimension of phosphorylation effects remains nonetheless poorly understood, particularly for intrinsically disordered proteins. Osteopontin, selected for this study due to its key role in biomineralization, is expressed in many species and tissues to play a range of distinct roles. A notable property of highly phosphorylated isoforms of osteopontin is their ability to sequester nanoclusters of calcium phosphate to form a core-shell structure, in a fluid that is supersaturated but stable. In Biology, this process enables soft and hard tissues to coexist in the same organism with relative ease. Here, we extend our understanding of the effect of phosphorylation on a disordered protein, the recombinant human-like osteopontin rOPN. The solution structures of the phosphorylated and unphosphorylated rOPN were investigated by small-angle x-ray scattering and no significant changes were detected on the radius of gyration or maximum interatomic distance. The picosecond-to-nanosecond dynamics of the hydrated powders of the two rOPN forms were further compared by elastic and quasi-elastic incoherent neutron scattering. Phosphorylation was found to block some nanosecond side-chain motions while increasing the flexibility of other side chains on the faster timescale. Phosphorylation can thus selectively change the dynamic behavior of even a highly disordered protein such as osteopontin. Through such an effect on rOPN, phosphorylation can direct allosteric mechanisms, interactions with substrates, cofactors and, in this case, amorphous or crystalline biominerals.

Indexed as

AnimalsCattleElasticityElectrophoresis, Polyacrylamide GelEndopeptidase KEscherichia coliHorsesHumansMolecular Dynamics SimulationNeutron DiffractionNuclear Magnetic Resonance, BiomolecularOsteopontinPhosphorylationProteolysisProton Magnetic Resonance SpectroscopyRecombinant ProteinsEndopeptidase KOsteopontinRecombinant ProteinsSolutionsSPP1 protein, humanWater

Identifiers

PMID28445750
PMCPMC5406370
OpenAlexW2608361507

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.